Price Alert

Sinopharm Group Co. Ltd. (SHTDY)

OTC: SHTDY · Real-Time Price · USD

12.51

0.19 (1.50%)

At close: Aug 15, 2025, 3:50 PM

12.48

-0.27%

After-hours: Aug 15, 2025, 03:17 PM EDT

Sinopharm Balance Sheet Statement

Financials in CNY. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Dec 31, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Cash & Equivalents	54.31B	43.33B	48.91B	63.81B	44.26B	34.38B	47.2B	55.22B	38.21B	32.15B	35.91B	43.53B	33.14B	34.36B	-52.85B
Short-Term Investments	158K	553K	146.27K	547K	395.33K	422K	439.56K	498K	266.84K	347K	364.86K	11.75M	11.54M	169K	105.7B
Long-Term Investments	10.89B	10.6B	10.78B	10.55B	10.28B	10.09B	10.05B	9.84B	9.55B	9.64B	9.4B	9.17B	8.34B	8.74B	n/a
Other Long-Term Assets	3.5B	6.4B	9.08B	3.95B	8.85B	3.55B	8.94B	3.73B	8.71B	3.58B	8.58B	3.73B	9.24B	4B	-52.85B
Receivables	206.72B	260.29B	232.58B	185.79B	243.85B	241.48B	220.13B	171.2B	225.75B	211.75B	205.66B	172.58B	202.95B	191.11B	n/a
Inventory	62.35B	68.84B	64.59B	60.03B	66.29B	66.92B	67.33B	60.93B	59.28B	56.99B	56.3B	51.5B	52.07B	50.82B	n/a
Other Current Assets	14.05B	27.78B	18.47B	23.88B	18.26B	29.38B	20.22B	28.86B	17.3B	24.37B	16.73B	20.49B	16.18B	23.66B	n/a
Total Current Assets	347.45B	382.36B	364.54B	336.84B	372.67B	372.15B	354.87B	319.41B	340.55B	325.26B	314.61B	290.92B	304.34B	299.95B	52.85B
Property-Plant & Equipment	17.61B	20.1B	17.19B	18.05B	16.63B	19.66B	16.52B	17.79B	16.36B	19.38B	16.38B	17.6B	16.25B	18.94B	n/a
Goodwill & Intangibles	10.97B	10.12B	11.48B	12.04B	11.51B	10.14B	11.52B	12.03B	11.66B	10.29B	11.59B	12.2B	12.25B	11.01B	n/a
Total Long-Term Assets	45.38B	47.22B	48.52B	46.56B	47.28B	45.54B	47.03B	45.37B	46.28B	44.92B	45.95B	44.49B	46.08B	44.38B	-52.85B
Total Assets	392.83B	429.58B	413.07B	383.39B	419.95B	417.69B	401.9B	364.78B	386.83B	370.18B	360.56B	335.41B	350.42B	344.33B	n/a
Account Payables	156.87B	155.83B	149.36B	146.63B	159.01B	156.64B	149.07B	137.09B	146.28B	131.28B	131.05B	128.43B	127.78B	121.33B	n/a
Deferred Revenue	n/a	-4.21B	1.58B	22.72B	n/a	n/a	n/a	28B	n/a	n/a	n/a	21.62B	n/a	n/a	n/a
Short-Term Debt	62.73B	79.69B	62.96B	54.73B	67.93B	74.67B	53.78B	53B	59.71B	76.66B	69.4B	55.15B	63.28B	71.83B	n/a
Other Current Liabilities	16.57B	6.94B	54.05B	29.5B	50.06B	13.21B	60.75B	33.67B	52.42B	10.45B	40.21B	25.82B	42.59B	10.05B	n/a
Total Current Liabilities	250.38B	283.24B	267.96B	241.49B	278.76B	281.31B	265.4B	234.96B	260.08B	248.98B	242.15B	219.31B	235.15B	232.32B	n/a
Long-Term Debt	8.64B	15.93B	14.29B	13.83B	17.45B	15.23B	15.77B	11.75B	12.93B	10.38B	8.49B	8.42B	10.6B	10.32B	n/a
Other Long-Term Liabilities	2.82B	4.31B	4.18B	4.33B	4.41B	4.74B	4.36B	4.79B	4.27B	3.65B	4.28B	4.78B	4.81B	3.76B	n/a
Total Long-Term Liabilities	15.77B	23.91B	22.24B	21.59B	25.25B	23.27B	23.4B	19.74B	20.56B	18.45B	16.14B	16.45B	18.9B	18.84B	n/a
Total Liabilities	266.14B	307.15B	290.2B	263.08B	304.01B	304.58B	288.79B	254.71B	280.65B	267.43B	258.29B	235.76B	254.05B	251.15B	n/a
Total Debt	76.39B	101.06B	77.26B	73.78B	88.77B	94.83B	72.81B	69.59B	76B	91.9B	81.27B	68.37B	77.37B	86.79B	n/a
Common Stock	3.12B	3.12B	3.12B	3.12B	3.12B	3.12B	3.12B	3.12B	3.12B	3.12B	3.12B	3.12B	3.12B	3.12B	n/a
Retained Earnings	53.74B	50.4B	52.55B	49.41B	48.19B	n/a	46.28B	42.87B	42B	n/a	39.91B	38.52B	36.44B	n/a	n/a
Comprehensive Income	n/a	n/a	15.68M	22.06B	20.05M	66.49B	18.1M	-4.39B	18.02M	60.12B	8M	-4.39B	5.32M	54.67B	56.36B
Shareholders Equity	78.88B	75.54B	76.13B	74.58B	71.76B	69.6B	69.84B	68.07B	65.56B	63.24B	63.47B	61.89B	59.96B	57.79B	89.95B
Total Investments	10.89B	10.6B	10.78B	10.55B	10.28B	10.09B	10.06B	9.84B	9.55B	9.64B	9.4B	9.18B	8.35B	8.74B	105.7B